References
- Akkas SB, Severcan M, Yilmaz O, Severcan F. Effects of lipoic acid supplementation on rat brain tissue: An FTIR spectroscopic and neural network study. Food Chem, 2007;105:1281–8
- Bai MY, Chou TC, Tsai JC, Yang HC. Active ingredient-containing chitosan/polycaprolactone nonwoven mats: Characterizations and their functional assays. Mater Sci Eng C, 2013;33:224–33
- Brouwer J, Van Leeuwen-Herberts T, Otting-van de Ruit M. Determination of lysozyme in serum, urine, cerebrospinal fluid and feces by enzyme immunoassay. Clin Chim Acta, 1984;142:21–30
- Freier T, Koh HS, Kazazian K, Shoichet MS. Controlling cell adhesion and degradation of chitosan films by N-acetylation. Biomaterials, 2005;26:5872–8
- Huang M, Khor E, Lim LY. Uptake and cytotoxicity of chitosan molecules and nanoparticles: Effects of molecular weight and degree of deacetylation. Pharm Res, 2004;21:344–53
- Jacob S, Ruus P, Hermann R, Tritschler HJ, Maerker E, Renn W, Augustin HJ, Dietze GJ, Rett K. Oral administration of rac-a-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: A placebo-controlled pilot trial. Free Radical Biol Med, 1999;27:309–14
- Kofuji K, Isobe T, Murata Y. Controlled release of alpha-lipoic acid through incorporation into natural polysaccharide-based gel beads. Food Chem, 2009;115:483–7
- Nordtveit RJ, Varum KM, Smidsrod O. Degradation of fully water-soluble, partially N-acetylated chitosans with lysozyme. Carbohydr Polym, 1994;23:253–60
- Nordtveit RJ, Varum KM, Smidsrod O. Degradation of partially N-acetylated chitosans with hen egg white and human lysozyme. Carbohydr Polym, 1996;29:163–7
- Park S, Hwang S, Lee J. pH-responsive hydrogels from moldable composite microparticles prepared by coaxial electro-spray drying. Chem Eng J, 2011;169:348–57
- Poon GM, Gariépy J. Cell-surface proteoglycans as molecular portals for cationic peptide and polymer entry into cells. Biochem Soc Trans, 2007;35:788–93
- Poon HF, Farr SA, Thongboonkerd V, Lynn BC, Banks WA, Morley JE, Klein JB, Butterfield DA. Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: Implications for aging and age-related neurodegenerative disorders. Neurochem Int, 2005;46:159–68
- Porstmann B, Jung K, Schmechta H, Evers U, Pergande M, Porstmann T, Kramm HJ, Krause H. Measurement of lysozyme in human body fluids: Comparison of various enzyme immunoassay techniques and their diagnostic application. Clin Biochem, 1989;22:349–55
- Sashiwa H, Saimoto H, Shigemasa Y, Ogawa R, Tokura S. Lysozyme susceptibility of partially deacetylated chitin. Int J Biol Macromol, 1990;12:295–6
- Schnürch AB, Rohrwig ER, Marschütz M, Schuhbauer H, Kratzel M. Development of a sustained release dosage form for α-lipoic acid. II. Evaluation in human volunteers. Drug Dev Ind Pharm, 2004a;30:35–42
- Schnürch AB, Schuhbauer H, Clausen AE, Hanel R. Development of a sustained release dosage form for α-lipoic acid. I. Design and in vitro evaluation. Drug Dev Ind Pharm, 2004b;30:27–34
- Teichert J, Kern J, Tritschler HJ, Ulrich H, Preib R. Investigations on the pharmacokinetics of a-lipoic acid in healthy volunteers. Int J Clin Pharmacol Ther, 1998;36:625–8
- Weerakody R, Fagan P, Kosaraju SL. Chitosan microspheres for encapsulation of alpha-lipoic acid. Int J Pharm, 2008;357:213–8
- Wollin SD, Jones PJH. Alpha lipoic acid and cardiovascular disease. J Nutr, 2003;133:3327–30